Journal article

Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

Peter Hillmen, Petra Muus, Alexander Roeth, Modupe O Elebute, Antonio M Risitano, Hubert Schrezenmeier, Jeffrey Szer, Paul Browne, Jaroslaw P Maciejewski, Joerg Schubert, Alvaro Urbano-Ispizua, Carlos de Castro, Gerard Socie, Robert A Brodsky

British Journal of Haematology | WILEY | Published : 2013

Grants

Funding Acknowledgements

P.H. served on an advisory committee for and received honoraria from Alexion Pharmaceuticals. P.M. served on an advisory committee for Alexion Pharmaceuticals. A.R. served on an advisory committee for and received honoraria and research funding from Alexion Pharmaceuticals. M.O.E. served on an advisory committee for and received honoraria from Alexion Pharmaceuticals. A.M.R. served on an advisory committee for and received honoraria from Alexion Pharmaceuticals. H.S. served on an advisory committee for and received honoraria and research funding from Alexion Pharmaceuticals and received honoraria from Genzyme. J.S. served as a consultant for and received honoraria from Alexion Pharmaceuticals, Ortho Biotech and Roche. P.B. has nothing to disclose. J.P.M. served as a consultant for Alexion Pharmaceuticals and received research funding from Celgene and Eisai. J.S. served on an advisory committee for and received honoraria from Alexion Pharmaceuticals and served on advisory committees for Celgene, Novartis and Pfizer. A.U.-I. served on an advisory committee for Alexion Pharmaceuticals. C.D. served on a speakers bureau for Alexion Pharmaceuticals. G.S. served as a consultant for Alexion Pharmaceuticals and served on advisory committees for and received honoraria from Therakos and Fressenius. R.A.B. served on an advisory committee for Alexion Pharmaceuticals.